General Information of the Compound
| Compound ID |
CP0422241
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S)-3-[4-[[4-methyl-5-(spiro[indene-1,4'-piperidine]-1'-ylmethyl)-1,3-thiazol-2-yl]methoxy]phenyl]hex-4-ynoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H32N2O3S
|
||||||||||||||||||
| Molecular Weight |
512.675
|
||||||||||||||||||
| Canonical SMILES |
CC#C[C@@H](CC(O)=O)c1ccc(OCc2nc(C)c(CN3CCC4(CC3)C=Cc3ccccc43)s2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H32N2O3S/c1-3-6-25(19-30(34)35)23-9-11-26(12-10-23)36-21-29-32-22(2)28(37-29)20-33-17-15-31(16-18-33)14-13-24-7-4-5-8-27(24)31/h4-5,7-14,25H,15-21H2,1-2H3,(H,34,35)/t25-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SXBDSTLZQNSEGA-VWLOTQADSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04613, Free fatty acid receptor 1
Protein ID: PT02793, Free fatty acid receptor 1
Protein ID: PT02522, Free fatty acid receptor 1